Ciaffoni Joseph's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Jun 2, 2023
- Accession no.
- 0001062993-23-012809
- Filed
- Jun 2, 2023
- Trade date
- Jun 1-2, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.37M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaffoni JosephCIK 0001443841 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | SSaleDisposed | −31,272 | $22.09 | −$690,798.48 | 306,272 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −30,272 | $21.58 | −$653,269.76 | 276,000 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −1,000 | $22.25 | −$22,250 | 275,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.